Alcyone Lifesciences has raised $1.8 million in its first round of venture capital, the company disclosed in a regulatory filing. 14 investors participated in the offering. A principal of MPM Capital is a Co-Founder of the company.
Alcyone is focused on developing products for treatment of difficult and chronic neuropathological conditions.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/Alcyone%20Lifesciences/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
